Efficacy of HPV DNA testing with cytology triage and/or repeat HPV DNA testing in primary cervical cancer screening.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Journal of the National Cancer Institute

• Publication date

  2009-01-21

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/jnci/djn444PMID 19141778
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Liquid Compared With Conventional Cervical Cytology: A Systematic Review and Meta-analysis

  2008cited by this paper
• Human Papillomavirus and Papanicolaou Tests to Screen for Cervical Cancer

  2008cited by this paper
• Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial.

  2007cited by this paper
• Liquid‐based cytology versus conventional Papanicolaou smear in an organized screening program

  2007cited by this paper
• Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer.

  2007cited by this paper
• Risk of high‐grade cervical intra‐epithelial neoplasia based on cytology and high‐risk HPV testing at baseline and at 6‐months

  2007cited by this paper
• Human papillomavirus and Papanicolaou tests to screen for cervical cancer.

  2007cited by this paper
• HPV type-specific risks of high-grade CIN during 4 years of follow-up: A population-based prospective study

  2007cited by this paper
• Chapter 9: Clinical applications of HPV testing: a summary of meta-analyses.

  2006cited by this paper
• Human papillomavirus testing and liquid-based cytology: results at recruitment from the new technologies for cervical cancer randomized controlled trial.

  2006cited by this paper
• HPV testing in routine cervical screening: cross sectional data from the ARTISTIC trial

  2006cited by this paper
• Human Papillomavirus Type–Specific 18-Month Risk of High-Grade Cervical Intraepithelial Neoplasia in Women with a Normal or Borderline/Mildly Dyskaryotic Smear

  2006cited by this paper
• Overview of the European and North American studies on HPV testing in primary cervical cancer screening

  2006cited by this paper
• Human papillomavirus testing and liquid-based cytology in primary screening of women younger than 35 years: results at recruitment for a randomised controlled trial.

  2006cited by this paper
• The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice.

  2005cited by this paper
• Colposcopic and histopathologic evaluation of women participating in population-based screening for human papillomavirus deoxyribonucleic acid persistence.

  2005cited by this paper
• Virologic versus cytologic triage of women with equivocal Pap smears: a meta-analysis of the accuracy to detect high-grade intraepithelial neoplasia.

  2004cited by this paper
• Interim Guidance for the Use of Human Papillomavirus DNA Testing as an Adjunct to Cervical Cytology for Screening

  2004cited by this paper
• POBASCAM, a population‐based randomized controlled trial for implementation of high‐risk HPV testing in cervical screening: Design, methods and baseline data of 44,102 women

  2004cited by this paper
• Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance.

  2003cited by this paper
• Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis.

  2003cited by this paper
• The 2001 Bethesda System terminology.

  2003cited by this paper
• Management of women who test positive for high-risk types of human papillomavirus: the HART study.

  2003cited by this paper
• Essential Medical Statistics

  2003cited by this paper
• Epidemiologic classification of human papillomavirus types associated with cervical cancer.

  2003cited by this paper
• Population‐based type‐specific prevalence of high‐risk human papillomavirus infection in middle‐aged Swedish Women

  2002cited by this paper
• Use of human papillomavirus DNA testing to compare equivocal cervical cytologic interpretations in the United States, Scandinavia, and the United Kingdom

  2002cited by this paper
• Accuracy of the Papanicolaou Test in Screening for and Follow‐up of Cervical Cytologic Abnormalities: A Systematic Review

  2001cited by this paper
• Accuracy of the Papanicolaou Test in Screening for and Follow-up of Cervical Cytologic Abnormalities

  2000cited by this paper
• Trends in cancer of the cervix uteri in Sweden following cytological screening

  1999cited by this paper
• Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer.

  1999cited by this paper
• International incidence rates of invasive cervical cancer after introduction of cytological screening

  1997cited by this paper
• A general primer GP5+/GP6(+)-mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings

  1997cited by this paper
• HPV Prevalence in cytomorphologically normal cervical scrapes of pregnant women as determined by PCR: The age‐related pattern

  1995cited by this paper
• [Modern epidemiology].

  1971cited by this paper
• Diagnostic Cytology and Its Histopathologic Bases

  1969cited by this paper
• Diagnostic cytology and its histopathologic bases

  1968cited by this paper

• Extended HPV genotyping and dual stain for the triage of primary HPV screen‐positive cases: Practical guidance for the cytopathology laboratory

  2025cites this paper
• Clinical Validation of the Venus HPV Full‐Genotyping Assay for Cervical Cancer Screening in the VALGENT‐4 Framework

  2025cites this paper
• Short-term repeat HPV testing for triaging HPV-positive women in cervical cancer screening

  2025cites this paper
• Risk of high‐grade cervical lesions in the second round of primary human papillomavirus testing in CervicalScreen Norway: A population‐based cohort study

  2025cites this paper
• Should we use risk selection tests for HPV 16 and/or 18 positive cases: Comparison of p16/Ki67 and cytology

  2024cites this paper
• Prevalence of higher-grade dysplasia in persistently high-risk human papillomavirus positive, cytology negative women after introduction of the new cervical cancer screening in Germany

  2023cites this paper
• Curcumin suppressed the proliferation and apoptosis of HPV‐positive cervical cancer cells by directly targeting the E6 protein

  2023cites this paper
• Genotyping and Cytology Triage of High-Risk HPV DNA Positive Women for Detection of Cervical High-Grade Lesions

  2022cites this paper
• Alternative cytology triage strategies for primary HPV screening.

  2022cites this paper
• Role of Dual-Staining p16/Ki-67 in the Management of Patients under 30 Years with ASC-US/L-SIL

  2022cites this paper
• Diagnostic distribution and pitfalls of glandular abnormalities in cervical cytology: a 25-year single-center study

  2022cites this paper
• New Aspects and an Artificial Intelligence Approach for the Detection of Cervical Abnormalities

  2022cites this paper
• A szervezett lakossági méhnyakszűrés részvételi mutatói Magyarországon

  2022cites this paper
• [Participation indicators of organized cervical cancer screening in Hungary].

  2022cites this paper
• The value of adding a single co-test in HPV primary screening.

  2021cites this paper
• Preliminary Study on the Expression of Testin, p16 and Ki-67 in the Cervical Intraepithelial Neoplasia

  2021cites this paper
• REVISITING THE EARLY DIAGNOSTICS OF DISPLASIA AND CERVICAL CANCER

  2021cites this paper
• The outcome of colposcopy in women attending with persistent postcoital bleeding and negative HPV-DNA test

  2021cites this paper
• Prevention and Screening of HPV Malignancies.

  2021cites this paper
• Benefit of double‐reading cytology smears as a triage strategy among high‐risk human papillomavirus–positive women in Mexico

  2020cites this paper
• Self-sampling for HPV testing in primary cervical screening Including clinical and health economic aspects

  2020cites this paper
• Risk of Cervical Intraepithelial Neoplasia Grade 3 or Worse in HPV-Positive Women with Normal Cytology and Five-Year Type Concordance: A Randomized Comparison

  2020cites this paper
• The impact of HPV-specific infection in women diagnosed with atypical glandular cells: Results from the HPV-AGC study.

  2020cites this paper
• Multicentric assessment of cervical HPV infection co-factors in a large cohort of Greek women

  2020cites this paper
• Prevalence and prevention of sexually transmitted viral infections in women from the Bolivian Amazonas

  2020cites this paper
• Primary HPV screening for cervical cancer: Results after two screening rounds in a regional screening program in Finland

  2020cites this paper
• Role of molecular biomarker human papilloma virus (HPV) E6 oncoprotein in cervical cancer screening.

  2020cites this paper
• Changes in the genetic landscape during the malignization of high grade squamous intraepithelial lesion into cervical cancer.

  2020cites this paper
• FAM19A4/miR124-2 methylation analysis as a triage test for HPV-positive women: cross-sectional and longitudinal data from a Dutch screening cohort.

  2020cites this paper
• Evaluation of six methylation markers derived from genome-wide screens for detection of cervical precancer and cancer.

  2020cites this paper
• Clinical relevance of partial HPV16/18 genotyping in stratifying HPV‐positive women attending routine cervical cancer screening: a population‐based cohort study

  2020cites this paper
• HPV-based cervical screening: Rationale, expectations and future perspectives of the new Dutch screening programme.

  2019influential citation
• "Sexually transmitted infections - laboratory diagnosis".

  2019cites this paper
• Profile of MeltPro® HPV test for human papillomavirus genotyping and cervical precancer screening

  2019cites this paper
• Validity and Reliability of the Persian Version of Emotion Thermometers in Iranian Advanced Cancer Patients

  2019cites this paper
• Performance of Two-Stage Cervical Cancer Screening With Primary High-Risk Human Papillomavirus Testing in Women Living With Human Immunodeficiency Virus.

  2019cites this paper
• Diagnostic performance of the E6/E7 mRNA-based Optimygene HR-HPV RT-qDx assay for cervical cancer screening.

  2019cites this paper
• Sexually transmitted infections - laboratory diagnosis.

  2019cites this paper
• Management of HPV‐positive women in cervical screening using results from two consecutive screening rounds

  2019cites this paper
• Genital self-sampling for HPV-based cervical cancer screening: a qualitative study of preferences and barriers in rural Ethiopia

  2019cites this paper
• Cost-effectiveness evaluation of HPV self-testing offered to non-attendees in cervical cancer screening in Switzerland.

  2019cites this paper
• Prueba de concepto de una PCR multiplex de primera generación (cualitativa) para detección del oncogén E7 de VPHS de alto riesgo

  2019cites this paper
• Improving Early Diagnosis of Cervical Cancer Lesions Using P16INK4a Biomarkers on Cellblocks from Cervical Smears

  2019cites this paper
• FACTORS ASSOCIATED WITH PERSISTENCE OF HPV GENITAL INFECTION IN A SMALL COHORT OF ROMANIAN WOMEN

  2019cites this paper
• High-Risk HPV Screening for Cervical Cancer

  2019cites this paper
• An Artificial Intelligence Approach for the Detection of Cervical Abnormalities

  2019cites this paper
• Prevention of Cervical Cancer. Guideline of the DGGG and the DKG (S3 Level, AWMF Register Number 015/027OL, December 2017) – Part 2 on Triage, Treatment and Follow-up

  2019cites this paper
• INFECÇÕES SEXUALMENTE TRANSMISSÍVEIS: CONHECER PARA PREVENIR

  2019cites this paper
• Five‐year risk of CIN3 after short‐term HPV‐DNA negativity in cytology‐negative women: a population‐based cohort study

  2019cites this paper
• What Has Changed Since the Introduction of Human Papillomavirus Testing with the Cytology-Based Cervical Cancer Screening System in Japan A Social Experiment

  2019cites this paper
• Baseline findings and safety of infrequent vs. frequent screening of human papillomavirus vaccinated women

  2019cites this paper
• Cervical Cancer Screening ( PDQ ® ) – Health Professional Version

  2019cites this paper
• Cervical Cancer Screening Programs in Europe: The Transition Towards HPV Vaccination and Population-Based HPV Testing

  2018cites this paper
• HPV Screening in the way to cervical cancer elimination

  2018cites this paper
• Cervical cancer risk in HPV‐positive women after a negative FAM19A4/mir124‐2 methylation test: A post hoc analysis in the POBASCAM trial with 14 year follow‐up

  2018cites this paper
• Automated Cervical Screening and Triage, Based on HPV Testing and Computer-Interpreted Cytology

  2018cites this paper
• Clinical Evaluation of INNO-LiPA HPV Genotyping EXTRA II Assay Using the VALGENT Framework

  2018cites this paper
• Update on primary HPV screening for cervical cancer prevention.

  2018cites this paper
• Assessment of the Roche Linear Array HPV Genotyping Test within the VALGENT framework.

  2018cites this paper
• Detection of high-grade neoplasia in air-dried cervical PAP smears by a microRNA-based classifier

  2018cites this paper
• Bench to Bedside - Research aspects

  2018cites this paper
• Cervical Cancer Prevention and Control

  2018cites this paper
• Prediction of Cervical Cancer Based on the Life Style, Habits, and Diseases Using Regression Analysis Framework

  2018cites this paper
• Prediction of Cervical Cancer Based on the Life Style, Habits, and Diseases Using Regression Analysis Framework

  2018cites this paper
• Improving the effectiveness of screening and treatment of HSIL pathologies

  2018cites this paper
• Human papillomavirus type specific risk of progression and remission during long‐term follow‐up of equivocal and low‐grade HPV‐positive cervical smears

  2018cites this paper
• HPV-positive women with normal cytology remain at increased risk of CIN3 after a negative repeat HPV test

  2017cites this paper
• Impact of different educational interventions on psychosocial well-being of women with a positive high-risk human papillomavirus and normal cervical cytology: a randomised trial

  2017cites this paper
• Cytology versus HPV testing for cervical cancer screening in the general population.

  2017cites this paper
• Characterization and clinical validation of MCM2 and TOP2A monoclonal antibodies in the BD ProEx™ C assay: An immunoassay which detects aberrant S-phase induction in cervical tissue.

  2017cites this paper
• Understanding the Role of Oncogenic Human Papillomavirus (HPV) Status on Adherence Behaviors Among Women with Abnormal Cervical Cytology

  2017cites this paper
• Human Papillomavirus (HPV) Detection in Cytologic Specimens: Similarities and Differences of Available Methodology

  2017cites this paper
• Comparison of Triage Strategies for HPV-Positive Women: Canadian Cervical Cancer Screening Trial Results

  2017cites this paper
• HPV-negative CIN3 and cervical cancer in Switzerland: any evidence of impact on screening policies?

  2017cites this paper
• Approaches for triaging women who test positive for human papillomavirus in cervical cancer screening.

  2017cites this paper
• Stratifying HPV‐positive women for CIN3+ risk after one and two rounds of HPV‐based screening

  2017cites this paper
• Cervical Screening: History, Current Algorithms, and Future Directions

  2017cites this paper
• Cervical cancer prevention in Japan: present status and issues@@@―現状と課題―

  2017cites this paper
• The Use of Self-sampling for HPV Testing to Improve Cervical Cancer Screening Participation among Under-screened Women Living in Rural Ontario

  2017cites this paper
• Molecular tests potentially improving HPV screening and genotyping for cervical cancer prevention

  2017cites this paper
• HPV L1 and P16 Expression in CIN1 to Predict Future CIN2+

  2017cites this paper
• Development of a clinical decision support system using genetic algorithms and Bayesian classification for improving the personalised management of women attending a colposcopy room.

  2016cites this paper
• Triage of high-risk HPV positive women in cervical cancer screening

  2016cites this paper
• Cost-effectiveness of prevention strategies against cervical cancer in women, Vientiane, Lao PDR

  2016influential citation
• [HPV primary test in the cervical cancer screening: reproducibility assessment and investigation on cytological outcome of Hybrid Capture 2 borderline samples].

  2016cites this paper
• Human Papillomavirus Laboratory Testing: the Changing Paradigm

  2016cites this paper
• A Suggested Approach to Simplify and Improve Cervical Screening in the United States

  2016cites this paper
• Safety of extending screening intervals beyond five years in cervical screening programmes with testing for high risk human papillomavirus: 14 year follow-up of population based randomised cohort in the Netherlands

  2016cites this paper
• Cervical cytology ASCUS patients with HPV detection and clinical value.

  2016cites this paper
• Cervical Cancer And Its Primary Screening In China, India And Nepal

  2016cites this paper
• HPV Detection Methods: Towards Personalized Prevention

  2016cites this paper
• Detección de virus del papiloma humano en muestras de hisopados vaginales por autotoma

  2015cites this paper
• Claudin-1 as a Biomarker of Cervical Cytology and Histology

  2015cites this paper
• HPV-DNA -positiivisuuden vaikutus nuorten naisten elämänlaatuun

  2015cites this paper
• HPV infection-associated anogenital cyto-colpo-histological findings and molecular typing in HIV-positive women.

  2015cites this paper
• The Application of Classification and Regression Trees for the Triage of Women for Referral to Colposcopy and the Estimation of Risk for Cervical Intraepithelial Neoplasia: A Study Based on 1625 Cases with Incomplete Data from Molecular Tests

  2015cites this paper
• European guidelines for quality assurance in cervical cancer screening. Summary of the supplements on HPV screening and vaccination

  2015cites this paper
• Adjunct screening of cervical or vaginal samples using careHPV testing with Pap and aided visual inspection for detecting high-grade cervical intraepithelial neoplasia.

  2015cites this paper
• HPV DNA testing with cytology triage in cervical cancer screening: Influence of revealing HPV infection status

  2015cites this paper
• European Code against Cancer, 4th Edition: Cancer screening.

  2015cites this paper